ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Nephrology Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT BYNUM MD

Nephrology

18,551

$1.43M

656
489 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 27%

$77
Average prescription price

Avg: $113

STEWART MANNING M.D.

Nephrology

8,472

$739K

300
215 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 27%

$87
Average prescription price

Avg: $113

ANWAR AL-HAIDARY

Nephrology

8,469

$1.18M

520
353 are 65+

14%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 27%

$139
Average prescription price

Avg: $113

DANILO BERNARDO MD

Nephrology

7,512

$597K

376
210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $113

STUART HAIGLER MD

Nephrology

6,957

$916K

469
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 27%

$132
Average prescription price

Avg: $113

LORENZO SANTARINA MD

Nephrology

6,784

$849K

457
265 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 27%

$125
Average prescription price

Avg: $113

HUGO TETTAMANTI MD

Nephrology

6,694

$426K

300
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $113

MICHAEL HOLLAND MD

Nephrology

6,658

$680K

454
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 27%

$102
Average prescription price

Avg: $113

BENJAMIN IGWEMEZIE M.D.

Nephrology

6,063

$403K

351
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $113

ROBERT DUNMIRE MD

Nephrology

5,744

$1.05M

323
157 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 27%

$183
Average prescription price

Avg: $113

GREG WARREN DO

Nephrology

5,689

$553K

354
215 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 27%

$97
Average prescription price

Avg: $113

JAMES MCCABE M.D.

Nephrology

5,649

$539K

433
225 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 27%

$96
Average prescription price

Avg: $113

PEALE CHUANG M.D.

Nephrology

5,139

$628K

437
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 27%

$122
Average prescription price

Avg: $113

JAMES DETERDING MD

Nephrology

5,112

$577K

447
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $113

CHARLES FRAZIER MD

Nephrology

5,082

$390K

178
90 are 65+

24%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 27%

$77
Average prescription price

Avg: $113

JOHN MANLEY M.D.

Nephrology

5,039

$688K

359
200 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 27%

$136
Average prescription price

Avg: $113

RAVI RAMSAMOOJ MD

Nephrology

5,010

$541K

345
224 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 27%

$108
Average prescription price

Avg: $113

STEPHEN SMITH M.D.

Nephrology

4,770

$571K

299
86 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 27%

$120
Average prescription price

Avg: $113

GREGORY PISEL M.D.

Nephrology

4,716

$392K

290
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 27%

$83
Average prescription price

Avg: $113

ROBERT KEMP MD

Nephrology

4,578

$494K

284
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 27%

$108
Average prescription price

Avg: $113

KARL BRANDSPIGEL MD

Nephrology

4,503

$532K

238
152 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 27%

$118
Average prescription price

Avg: $113

CHARLES JERE MD

Nephrology

4,454

$444K

415
208 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 27%

$100
Average prescription price

Avg: $113

JOEL BRUCE M.D.

Nephrology

4,404

$556K

318
149 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 27%

$126
Average prescription price

Avg: $113

VICKI STOVALL MD

Nephrology

4,302

$357K

235
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 27%

$83
Average prescription price

Avg: $113

WOLFGANG LOHRMANN MD

Nephrology

4,158

$356K

320
191 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 27%

$86
Average prescription price

Avg: $113

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank